-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Sangamo Therapeutics, Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2024.
- Sangamo Therapeutics, Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $98 K, a 49.5% decline year-over-year.
- Sangamo Therapeutics, Inc Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$5.17 M, a 1015% decline year-over-year.
- Sangamo Therapeutics, Inc annual Income Tax Expense (Benefit) for 2023 was -$5.07 M, a 1282% decline from 2022.
- Sangamo Therapeutics, Inc annual Income Tax Expense (Benefit) for 2022 was $429 K, a 40.2% increase from 2021.
- Sangamo Therapeutics, Inc annual Income Tax Expense (Benefit) for 2021 was $306 K, a 11.3% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)